291 related articles for article (PubMed ID: 12077085)
1. Risk factors for ulcer development in patients with non-ulcer dyspepsia: a prospective two year follow up study of 209 patients.
Hsu PI; Lai KH; Lo GH; Tseng HH; Lo CC; Chen HC; Tsai WL; Jou HS; Peng NJ; Chien CH; Chen JL; Hsu PN
Gut; 2002 Jul; 51(1):15-20. PubMed ID: 12077085
[TBL] [Abstract][Full Text] [Related]
2. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P
Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI
Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
[TBL] [Abstract][Full Text] [Related]
4. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori, non-steroidal anti-inflammatory drugs and smoking in risk pattern of gastroduodenal ulcers.
Konturek SJ; Bielański W; Płonka M; Pawlik T; Pepera J; Konturek PC; Czarnecki J; Penar A; Jedrychowski W
Scand J Gastroenterol; 2003 Sep; 38(9):923-30. PubMed ID: 14531527
[TBL] [Abstract][Full Text] [Related]
6. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
[TBL] [Abstract][Full Text] [Related]
7. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.
Huang JQ; Sridhar S; Hunt RH
Lancet; 2002 Jan; 359(9300):14-22. PubMed ID: 11809181
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori infection in non-ulcer dyspeptic and ulcer patients. Determinants and consequences in 'real life'.
Thürmer HL; Flaaten B; Erichsen KE; Lid NO; Solheim SB
Scand J Gastroenterol; 1996 Aug; 31(8):744-8. PubMed ID: 8858740
[TBL] [Abstract][Full Text] [Related]
9. Demographic and endoscopic characteristics of patients with Helicobacter pylori positive and negative peptic ulcer disease.
Xia HH; Phung N; Kalantar JS; Talley NJ
Med J Aust; 2000 Nov; 173(10):515-9. PubMed ID: 11194733
[TBL] [Abstract][Full Text] [Related]
10. Role of eradication of Cag A Helicobacter pylori in non ulcer dyspepsia.
Babu V; Kate V; Ananthakrishnan N
Trop Gastroenterol; 2005; 26(4):211-4. PubMed ID: 16737055
[TBL] [Abstract][Full Text] [Related]
11. Metronidazole-resistant Helicobacter pylori is more prevalent in patients with nonulcer dyspepsia than in peptic ulcer patients in a multiethnic Asian population.
Lui SY; Yeoh KG; Ho B
J Clin Microbiol; 2003 Nov; 41(11):5011-4. PubMed ID: 14605132
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
Gisbert JP; Legido J; García-Sanz I; Pajares JM
Dig Liver Dis; 2004 Feb; 36(2):116-20. PubMed ID: 15002818
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of and risk factors for Helicobacter pylori infection in a multi-racial dyspeptic Malaysian population undergoing endoscopy.
Goh KL
J Gastroenterol Hepatol; 1997 Jun; 12(6):S29-35. PubMed ID: 9195409
[TBL] [Abstract][Full Text] [Related]
14. Risk of ulcer bleeding in patients infected with Helicobacter pylori taking non-steroidal anti-inflammatory drugs.
Hawkey CJ
Gut; 2000 Mar; 46(3):310-1. PubMed ID: 10673289
[TBL] [Abstract][Full Text] [Related]
15. New CagL Amino Acid Polymorphism Patterns of
Caliskan R; Polat Sari S; Ercan B; Peker KD; Omac Sonmez M; Akgul O; Sapmaz B; Soylu A; Adas GT; Oner YA; Yuksel Mayda P
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556940
[No Abstract] [Full Text] [Related]
16. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of Helicobacter pylori-negative and -positive peptic ulcer disease.
Kemppainen H; Räihä I; Kujari H; Sourander L
Age Ageing; 1998 Jul; 27(4):427-31. PubMed ID: 9883997
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori negative, non-steroidal anti-inflammatory drug-negative peptic ulcers in India.
Goenka MK; Majumder S; Sethy PK; Chakraborty M
Indian J Gastroenterol; 2011 Feb; 30(1):33-7. PubMed ID: 21424697
[TBL] [Abstract][Full Text] [Related]
19. Relationship between non-steroidal anti-inflammatory drug use and Helicobacter pylori infection in bleeding or uncomplicated peptic ulcers: A case-control study.
Okan A; Tankurt E; Aslan BU; Akpinar H; Simsek I; Gonen O
J Gastroenterol Hepatol; 2003 Jan; 18(1):18-25. PubMed ID: 12519219
[TBL] [Abstract][Full Text] [Related]
20. Interaction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseases.
Ji KY; Hu FL
World J Gastroenterol; 2006 Jun; 12(24):3789-92. PubMed ID: 16804960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
